Lv4
650 积分 2024-07-10 加入
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR
19天前
已关闭
Real‐World Effectiveness and Safety of Biologic Switches in Chinese Patients With Plaque Psoriasis: A Single‐Center Retrospective Study
20天前
已完结
P115 Long-term outcomes of biologic-naive and biologic-experienced patients, with a focus on women of childbearing age with chronic plaque psoriasis treated with certolizumab pegol
20天前
已完结
P39 Outcomes after switching back to the originator adalimumab in psoriasis patients who previously switched to biosimilars
20天前
已完结
Treatment switching and associated economic outcomes in patients with plaque psoriasis treated with biologics: A retrospective analysis of German claims data 2016−2021
20天前
已完结
Podium Presentations
20天前
已完结
P002 Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data
20天前
已完结
AI02 (P002) Predicting psoriasis biologic drug discontinuation: an explainable machine learning approach applying British Association of Dermatologists Biologics and Immunomodulators Register data
20天前
已完结
Biologics/Psoriasis
20天前
已完结
How Much Frequently are Biological Drugs Used in Older Patients with Immune-Mediated Inflammatory Diseases? Results from the Large-Scale Italian Valore Distributed Database Network
20天前
已关闭
皖公网安备34019202002308
